Allarity Therapeutics, Inc.

As of May 19, 2025, Allarity Therapeutics, Inc. shows a bearish trend with weak strength indicators, despite some mixed signals from the MACD and RSI, leading to an overall bearish sentiment.

Allarity Therapeutics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $12.46 million. Key metrics include a negative P/E ratio, a 0.00% dividend yield, and a return on equity of -85.49%.

As of Jun 18, Allarity Therapeutics, Inc. has a market capitalization of 12.46 million, with net sales of 0.00 million and a net profit of -23.40 million over the last four quarters. The company reported shareholder's funds of 11.81 million and total assets of 22.65 million as of Dec 24.